APOTHEEK PALFIJN

Active

Public limited companyfounded 1994active for 31 yearsMeylandtlaan 159, 3550 Heusden-Zolder, BelgiumKBO/BCE: BE 0454.185.573

From the official registers: KBO 31 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK PALFIJN has been active since 1994 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €141,270 and a net result of €198,306. Equity is growing by about 3% per year across the filed financial years. Its solvency ranks better than 18% of 5,036 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

APOTHEEK PALFIJNActiveChecked score 88/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 29-12-1994 Normal situation
Legal form: Public limited company
Registered office: Meylandtlaan 159, 3550 Heusden-Zolder
Activity: Retail sale of pharmaceutical products NACE 47730
Establishment unit: 2.070.734.125 3550 Heusden-Zolder, since 15-03-1995
Financial year end: 31 December
Peppol: Reachable since 18-11-2025

Company details

Who decides

Board

APOTHEEK VALKENBORG BVManaging director · permanent representative Valkenborg Kathleen
VERBRUGGHE PietDirector · since 01-01-2022

Shareholders

APOTHEEK VALKENBORG100%annual accounts 2025

Board & ownership

How it is doing

88 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.2%

Annual accounts 2025

Gross margin: €327,739; ▲ 54.0%
Turnover: ≈ €1.2m; estimated
Profit: €198,306; ▲ 62.7%
Equity: €141,270; ▲ 0.2%
Total assets: €2.1m; ▲ 4.3%

2025 accounts filed 18 days late

Filed on 18-08-2026at the National Bank

Financials

Why 88raises riskEquity €141,270 (6.7% of total assets)Sector: Retail trade (NACE 47)lowers riskSize: total assets €2.1mFounded in 1994Show the evidence

Checked score

Score 2025

88 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 35% of its sector peers (NACE 47, small)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Weak

Solvency 32=

equity 6.7% of total assets

Liquidity 31-1

short-term debt 41.4% · cash 0.6%

Profitability 68+14

return on assets 9.4%

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (3,694 companies, NACE 47, small)

Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.3%▲ +0.1 percentage points vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.5%▲ +0.2 percentage points vs 06-2025 08-2025: 0.8%▲ +0.3 percentage points vs 07-2025 09-2025: 1.0%▲ +0.2 percentage points vs 08-2025highest value 10-2025: 0.2%▼ -0.8 percentage points vs 09-2025lowest value 11-2025: 0.2%● unchanged vs 10-2025lowest value 12-2025: 0.2%● unchanged vs 11-2025lowest value 01-2026: 0.2%● unchanged vs 12-2025lowest value 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.3%▲ +0.1 percentage points vs 06-2026 08-2026: 0.6%▲ +0.3 percentage points vs 07-2026 09-2026: 0.2%▼ -0.4 percentage points vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026

Credit of up to €12,000 on 30-day terms is acceptable

Liquidity insufficient (current ratio 0.78, compared with 0.71 in 2024, below 1; short-term debt: 41.4% and cash: 0.6% of total assets), and 93.3% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small): better than 18% on solvency, 32% on liquidity, 52% on profitability and 38% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises risk

Size: total assets €2.1m

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

Equity €141,270 (6.7% of total assets)

NBB · annual accounts

Sector: Retail trade (NACE 47)

KBO

Founded in 1994

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 5036 sector peers (2025).

NBB · sector comparison

Position among 5036 sector peers

Solvency

better than 18%

← weakest strongest →

2025 accounts filed 18 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 10 filings

Deviation from the deadline

2025

18 days late

2024

29 days late

2023

24 days late

2022

22 days late

2021

29 days late

2020

30 days late

2019

62 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 31 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 August (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Caution: Among the weakest 18% on solvencysector median 36.1% · 5,036 companies 6.7% View
Positive: Result rose in 2025from €121,907 to €198,306 ▲ 62.7% View
Positive: 8 profitable years in a rowprofit 2025: €198,306 8 years View

Documents

Key facts about APOTHEEK PALFIJN

What is the company number of APOTHEEK PALFIJN?: 0454.185.573. In Belgium the VAT number is the company number with BE in front: BE 0454.185.573.
Where is APOTHEEK PALFIJN based?: The registered office is at Meylandtlaan 159, 3550 Heusden-Zolder.Company details
What does APOTHEEK PALFIJN do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK PALFIJN?: Public limited company (NV).
When was APOTHEEK PALFIJN founded?: On 29-12-1994.
Is APOTHEEK PALFIJN still active?: Yes, APOTHEEK PALFIJN is an active enterprise in the KBO register.
What is the turnover of APOTHEEK PALFIJN?: ≈ €1.2m in financial year 2025. Estimated from the gross margin of €327,739: probably between €930,000 and €2.0m, based on 47 comparable companies, NACE 477.Financials
Is APOTHEEK PALFIJN profitable?: In financial year 2025, APOTHEEK PALFIJN made a profit of €198,306.
Where can I find the annual accounts of APOTHEEK PALFIJN?: APOTHEEK PALFIJN filed 31 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of APOTHEEK PALFIJN due?: By 31-07-2027, for financial year 2026.Timeline